Skip to main content
. 2020 Feb 12;318(3):R649–R656. doi: 10.1152/ajpregu.00233.2019

Table 3.

Nonsignificant changes in PVN mRNA expression

Marker Difference ± SE, AU P Value
Renin −0.06422 ± 0.08847 0.4783
AGT −0.1663 ± 0.1216 0.1903
ACE1 −0.2422 ± 0.1306 0.0823
AT1 −0.1094 ± 0.2290 0.6394
MR −0.08719 ± 0.1232 0.4895
NOX2 −0.2412 ± 0.2288 0.3075
CD11b −0.3328 ± 0.1770 0.0784
TNF-α −0.08678 ± 0.3540 0.8094
IL-1β −0.1908 ± 0.2752 0.4981
IL-6 −0.1093 ± 0.2349 0.648

mRNA expression that was nonsignificantly elevated in the paraventricular nucleus (PVN). Difference in mRNA expression (amphetamine – saline rats) is displayed in arbitrary units (AU) along with P values. All molecular markers examined were not significantly elevated by amphetamine pretreatment. ACE1, angiotensin-converting enzyme 1; AGT, angiotensinogen; AT1, angiotensin II receptor type 1; CD11b, cluster of differentiation molecule 11b; IL-1β, interleukin-1β; IL-6 interleukin-6; MR, mineralocorticoid receptor; NOX2, NADPH oxidase 2; TNF-α, tumor necrosis factor-α.

HHS Vulnerability Disclosure